Question 1

What is TRAXV free cash flow?

Accepted Answer

First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) generated $-126.16M in free cash flow on a trailing twelve-month basis, computed as operating cash flow minus capital expenditures.

Question 2

What is TRAXV operating cash flow?

Accepted Answer

First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued reports operating cash flow of $-125.81M TTM. Operating cash flow measures cash generated from core business operations.

Question 3

How much does TRAXV spend on capex?

Accepted Answer

First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued spent $358000.00 on capital expenditures (capex) in the most recent period.

Question 4

Where can I find TRAXV cash flow statement?

Accepted Answer

First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued's cash flow statement is sourced from official SEC filings and presented in annual and quarterly format. It includes operating, investing, and financing cash flows, capex, dividends, and share repurchases.

Item	2023	2024
Operating cash flow	$-93.00M	$-125.81M
Capital expenditures	$807000.00	$358000.00
Depreciation	—	—
Stock-based comp	$18.39M	$26.83M
Free cash flow	$-93.81M	$-126.16M
Investing cash flow	—	—
Financing cash flow	—	—
Dividends paid	—	—
Share repurchases	—	—
Debt repayment	—	—
Net change in cash	—	—

First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued

First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) Financial statements

Cash flow — annual